SOHONOS
NDC 15054-0025, palovarotene, capsule, from Ipsen Biopharmaceuticals, Inc..
- Product NDC
- 15054-0025
- Status
- Listed
- Labeler
- Ipsen Biopharmaceuticals, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215559
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/15054-0025 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PALOVAROTENE2.5 mg/1
Pharmacologic classes
Retinoid [EPC]; Retinoids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 15054-0025-1 | 15054002501 | 1 BLISTER PACK in 1 CARTON (15054-0025-1) / 14 CAPSULE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/67dce406-7cc4-4d66-92de-ad18b6df0625
Use it
Look up 15054-0025 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/15054-0025 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 15054-0025. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.